title: Prevalence and impact of substance use among emerging adults with serious mental health conditions.
abstract: OBJECTIVE
  This critical review of the literature integrates findings across varied literatures and identifies areas for continued study on the prevalence, correlates, and impact of substance use (alcohol and illicit drugs) on social role functioning among emerging adults with serious mental health conditions.
  
  
  OBJECTIVE
  This population is of interest because of high comorbidity rates between substance use and serious mental health conditions and the added difficulties posed by their co-occurrence during the transition to adulthood. This critical review presents the epidemiology of substance use in emerging adults with serious mental health conditions compared to emerging adults without these conditions, as well as what is known about predictors and consequences of substance use in this population.
  
  
  METHODS
  PsychINFO and PubMed along with relevant published literature.
  
  
  RESULTS
  This review summarizes what is known about the impact of these co-occurring problems on the transition of emerging adults from school and training environments to adult work roles. Though this group presents with unique challenges, few programs have been developed to address their specific needs. This paper synthesizes what is known empirically about approaches with this population, discussing those that might be useful for emerging adults with comorbid serious mental health conditions and substance use problems, particularly in supporting their educational and vocational development.
  
  
  CONCLUSIONS
  Emerging adults with co-occurring serious mental health conditions and substance use problems are underserved by current mental health systems. Recommendations focus on how to promote mental health and social role functioning through comprehensive intervention programs that provide continuity of care through the transition to adulthood.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC, USA. sheidoaj@musc.edu
authors.forename: Ashli J
authors.initials: AJ
authors.lastname: Sheidow
authors.forename: Michael
authors.initials: M
authors.lastname: McCart
authors.forename: Kristyn
authors.initials: K
authors.lastname: Zajac
authors.forename: Maryann
authors.initials: M
authors.lastname: Davis
mesh_terms: D000328:Adult; D015897:Comorbidity; D006801:Humans; D008603:Mental Health; D028642:Persons with Psychiatric Disorders / Q000523:psychology / Q000706:statistics & numerical data; D019989:Persons with Intellectual Disabilities / Q000523:psychology / Q000534:rehabilitation*; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D011613:Psychotherapy / Q000379:methods; D011618:Psychotic Disorders / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy
chemical_list: D011619:Psychotropic Drugs